![]() |
市场调查报告书
商品编码
1896205
全球免疫力增强食品、饮料和补充剂市场预测至2032年:按产品类型、形式、分销管道、性质、应用和地区分類的分析Immunity-Boosting Foods, Beverages & Supplements Market Forecasts to 2032 - Global Analysis By Product Type (Foods, Beverages, Supplements, and Other Product Types), Form, Distribution Channel, Nature, Application and By Geography |
||||||
根据 Stratistics MRC 的一项研究,全球增强免疫力的食品、饮料和补充剂市场预计到 2025 年价值 258.4 亿美元,到 2032 年达到 434.4 亿美元,在预测期内以 7.7% 的复合年增长率增长。
增强免疫力的食物、饮料和营养补充品旨在强化人体自身抵抗感染疾病和疾病的能力。这些包括富含维生素和矿物质的水果、蔬菜、草药,以及添加了抗氧化剂和益生菌的机能饮料。维生素C、维生素D、锌和植物萃取物等营养补充剂在维持免疫健康方面发挥重要作用。将这些产品融入日常生活中,可以增强免疫功能,促进整体健康,并有助于预防疾病,从而使其成为预防保健和健康策略的重要组成部分。
文明病及感染疾病呈上升趋势
久坐的生活方式、不良的饮食习惯和日益增长的压力正在削弱各年龄层的免疫力。消费者越来越倾向于积极主动地进行预防性保健,而非被动地接受治疗。富含维生素、矿物质、益生菌和抗氧化剂的机能性食品正被广泛接受。数位媒体和健康宣传活动提高了人们对免疫健康的认识,也影响他们的购买行为。人口老化和免疫力缺乏功能低下人群的增加也推动了市场需求的持续成长。随着免疫力成为健康的核心要素,製造商正在拓展产品系列,以满足多样化的健康需求。
缺乏标准化的临床证据
许多产品依赖传统知识和初步研究,而非大规模的同侪审查临床试验。成分品质、剂量和配方方面的差异使得产品的有效性难以持续检验。监管机构对健康声明的审查日益严格,给生产商带来了合规方面的挑战。消费者对过度宣传的怀疑也限制了消费者的信任。小规模品牌难以投入大量资源进行大规模的研究和检验。这些因素共同导致免疫增强类产品推广速度缓慢,并限制了其长期信誉。
对个人化营养和标靶免疫支持的需求日益增长
消费者越来越倾向于根据自身年龄、生活方式、饮食习惯和特定健康状况来寻求针对性的免疫解决方案。营养基因组学和微生物组研究的进步使得定製配方成为可能。数位健康平台和行动应用程式正在推动个人化营养补充剂推荐。品牌正在利用数据分析和人工智慧驱动的工具来提升消费者参与度和产品相关性。个人化订阅营养模式正在兴起,尤其是在都市区消费者中。这种向个人化免疫支援解决方案的转变,正在为那些推动创新的公司开闢新的成长途径。
现有品牌的激烈竞争
大型企业受益于强大的品牌知名度、广泛的分销网络和雄厚的营销预算。新参与企业在竞争激烈的市场中难以实现产品差异化。价格竞争和频繁的产品推出加剧了利润率的压力。现有品牌往往在线上和线下零售通路占据主导地位。零售商的自有品牌产品进一步加剧了动态。
新冠疫情的影响
新冠感染疾病显着改变了增强免疫力的食品、饮料和保健品市场。人们对免疫健康的日益重视,导致维生素、草药补充剂和机能饮料的需求激增。供应链中断最初影响了原料采购和生产能力。然而,疫情加速了数位化分销管道和直销模式的普及。监管机构暂时放宽了限制,以确保尖峰时段的产品供应。疫情过后,免疫产品已从短期预防用途转变为日常健康必需品。
预计在预测期内,膳食补充剂细分市场将占据最大的市场份额。
由于其便捷性、浓缩营养和广泛的供应管道,预计在预测期内,膳食补充剂细分市场将占据最大的市场份额。胶囊、锭剂、粉末和软糖等剂型服用方便,且便于精确控制剂量。消费者对维生素、矿物质、益生菌和草药萃取物的高度认知推动了强劲的需求。膳食补充剂被各个年龄层的人广泛用于预防和治疗免疫支持。频繁的产品创新和洁净标示配方提升了该细分市场的吸引力。在药局、超级市场和线上平台的广泛销售也提高了产品的供应量。
预计在预测期内,线上零售领域将呈现最高的复合年增长率。
在数位化和便利性的推动下,预计线上零售领域在预测期内将保持最高的成长率。电商平台提供种类繁多的免疫力产品,并附有透明的成分资讯和使用者评估。订阅模式和个人化推荐有助于提高客户维繫。极具竞争力的价格和宅配服务吸引了都市区消费者和精通科技的消费者。注重健康的线上市场的兴起正在扩大产品的覆盖范围。品牌正在利用社群媒体和网红行销来促进线上销售。
由于消费者健康意识强、购买力旺盛,预计北美地区在预测期内将占据最大的市场份额。消费者积极投资于预防性医疗保健和膳食补充剂。该地区拥有成熟的膳食补充剂产业,并具备强大的研发能力。有利的法规结构有利于免疫产品的快速商业化。文明病的高发生率进一步推动了市场需求。主要国际品牌的入驻也增强了市场渗透率。
由于快速的都市化和可支配收入的成长,预计亚太地区在预测期内将实现最高的复合年增长率。不断壮大的中产阶级越来越重视健康和保健。阿育吠陀和中草药等传统医学体係正在影响消费者的行为,旨在增强免疫力。疫情后人们对预防性医疗保健意识提升正在加速需求成长。电子商务平台的扩张正在改善全部区域的产品供应。各国政府正在推广营养和健康计划,以改善公众健康。
According to Stratistics MRC, the Global Immunity-Boosting Foods, Beverages & Supplements Market is accounted for $25.84 billion in 2025 and is expected to reach $43.44 billion by 2032 growing at a CAGR of 7.7% during the forecast period. Immunity-enhancing foods, drinks, and dietary supplements aim to fortify the body's natural defenses against infections and diseases. They encompass vitamin- and mineral-rich fruits, vegetables, herbs, and fortified functional beverages containing antioxidants and probiotics. Nutritional supplements such as vitamin C, vitamin D, zinc, and plant-based extracts play a crucial role in supporting immune health. Incorporating these products into daily routines can bolster immune function, promote overall well-being, and help prevent illnesses, positioning them as key elements in preventive healthcare and wellness strategies.
Increasing prevalence of lifestyle diseases and infections
Sedentary lifestyles, poor dietary habits, and rising stress levels have weakened immune resilience across populations. Consumers are becoming more proactive about preventive healthcare rather than reactive treatment. Functional foods fortified with vitamins, minerals, probiotics, and antioxidants are gaining widespread acceptance. Growing awareness about immune health through digital media and healthcare campaigns is influencing purchasing behavior. Aging populations and immunocompromised individuals further contribute to sustained market demand. As immunity becomes a core wellness priority, manufacturers are expanding product portfolios to address diverse health needs.
Lack of standardized clinical evidence
Many products rely on traditional knowledge or preliminary studies rather than large-scale, peer-reviewed clinical trials. Variability in ingredient quality, dosage, and formulation makes it difficult to validate efficacy consistently. Regulatory authorities are increasingly scrutinizing health claims, leading to compliance challenges for manufacturers. Consumer skepticism toward exaggerated marketing claims is also limiting trust. Smaller brands struggle to invest in extensive research and validation processes. These factors collectively slow product adoption and restrict long-term credibility in the immunity-boosting segment.
Rising demand for personalized nutrition and targeted immune-support
Consumers are increasingly seeking targeted immune solutions based on age, lifestyle, dietary preferences, and specific health conditions. Advances in nutrigenomics and microbiome research are enabling customized formulations. Digital health platforms and mobile applications are facilitating personalized supplement recommendations. Brands are leveraging data analytics and AI-driven tools to enhance consumer engagement and product relevance. Subscription-based personalized nutrition models are gaining traction, especially among urban consumers. This shift toward tailored immune-support solutions is creating new growth avenues for innovation-driven companies.
Intense competition from established brands
Large players benefit from strong brand recognition, extensive distribution networks, and significant marketing budgets. New entrants face difficulties in differentiating products in a crowded marketplace. Price competition and frequent product launches increase pressure on margins. Established brands often dominate shelf space in both offline and online retail channels. Private-label products from retailers are further intensifying competitive dynamics.
Covid-19 Impact
The COVID-19 pandemic significantly reshaped the immunity-boosting foods, beverages, and supplements market. Heightened awareness about immune health led to a sharp surge in demand for vitamins, herbal supplements, and functional beverages. Supply chain disruptions initially affected raw material sourcing and production capacities. However, the pandemic accelerated digital sales channels and direct-to-consumer models. Regulatory authorities temporarily eased norms to ensure product availability during peak demand. Post-pandemic, immunity products have transitioned from short-term preventive use to daily wellness essentials.
The supplements segment is expected to be the largest during the forecast period
The supplements segment is expected to account for the largest market share during the forecast period, due to its convenience, concentrated nutrition, and wide availability. Capsules, tablets, powders, and gummies offer easy consumption and precise dosage control. High consumer awareness of vitamins, minerals, probiotics, and herbal extracts supports strong demand. Supplements are widely used across age groups for preventive and therapeutic immune support. Frequent product innovations and clean-label formulations are enhancing segment attractiveness. Strong presence across pharmacies, supermarkets, and online platforms boosts accessibility.
The online retail segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the online retail segment is predicted to witness the highest growth rate, due to increasing digital adoption and convenience. E-commerce platforms offer a wide range of immunity products with transparent ingredient information and customer reviews. Subscription models and personalized recommendations are enhancing customer retention. Competitive pricing and doorstep delivery are attracting urban and tech-savvy consumers. The rise of health-focused online marketplaces is expanding product reach. Brands are leveraging social media and influencer marketing to drive online sales.
During the forecast period, the North America region is expected to hold the largest market share, due to high health awareness and strong purchasing power. Consumers actively invest in preventive healthcare and dietary supplements. The region has a well-established nutraceutical industry supported by robust R&D capabilities. Favorable regulatory frameworks enable faster commercialization of immunity products. High prevalence of lifestyle diseases further fuels demand. Strong presence of leading global brands enhances market penetration.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rapid urbanization and rising disposable incomes. Growing middle-class populations are increasingly prioritizing health and wellness. Traditional medicine systems such as Ayurveda and Traditional Chinese Medicine are influencing immunity-focused consumption. Increasing awareness of preventive healthcare post-pandemic is accelerating demand. Expansion of e-commerce platforms is improving product accessibility across the region. Governments are promoting nutrition and wellness initiatives to improve public health.
Key players in the market
Some of the key players profiled in the Immunity-Boosting Foods, Beverages & Supplements Market include Nestle S.A., Glanbia plc, Danone S.A., Nature's Way, Unilever PLC, Yakult Honsha, PepsiCo Inc., NOW Foods, The Coca-Cola Company, GNC Holdings Inc., Amway Corp., Abbott Laboratories, Herbalife, Pfizer Inc., and Bayer AG.
In November 2025, Nestle has been chosen to join the Frontier Firm AI Initiative, a multi-year collaboration launched by the Digital Data Design Institute at Harvard (D^3) and Microsoft. The initiative brings together forward-focused organizations and academic minds to explore and shape the future of human-led, AI-driven business.
In November 2025, Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics segments, serving millions more people. Under the terms of the agreement, Exact Sciences shareholders will receive $105 per common share, representing a total equity value of approximately $21 billion.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.